These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4576423)

  • 1. Soft gelatin capsules. I. Factors affecting capsule shell dissolution rate.
    Hom FS; Veresh SA; Miskel JJ
    J Pharm Sci; 1973 Jun; 62(6):1001-6. PubMed ID: 4576423
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzymes in the dissolution testing of gelatin capsules.
    Marques MR
    AAPS PharmSciTech; 2014 Dec; 15(6):1410-6. PubMed ID: 24942315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of enzymes and surfactants on the disintegration behavior of cross-linked hard gelatin capsules during dissolution.
    Pennings FH; Kwee BL; Vromans H
    Drug Dev Ind Pharm; 2006 Jan; 32(1):33-7. PubMed ID: 16455602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
    Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S; Jantratid E; Dressman JB
    J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water migration from soft gelatin capsule shell to fill material and its effect on drug solubility.
    Serajuddin AT; Sheen PC; Augustine MA
    J Pharm Sci; 1986 Jan; 75(1):62-4. PubMed ID: 3958908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
    Ofner CM; Zhang YE; Jobeck VC; Bowman BJ
    J Pharm Sci; 2001 Jan; 90(1):79-88. PubMed ID: 11064381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
    Garbacz G; Cadé D; Benameur H; Weitschies W
    Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
    Liu JP; Ma X; Zhu JB
    Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soft gelatin capsules II: Oxygen permeability study of capsule shells.
    Hom FS; Veresh SA; Ebert WR
    J Pharm Sci; 1975 May; 64(5):851-7. PubMed ID: 1151660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The shell dissolution of various empty hard capsules.
    Chiwele I; Jones BE; Podczeck F
    Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of agitation intensity, particle size and pH of dissolution fluid on the in-vitro release of drug from hard gelatin capsules.
    Newton JM; Muhammad NA
    J Pharm Pharmacol; 1984 Jan; 36(1):42-4. PubMed ID: 6141262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of active insoluble pepsin.
    Rao SS; Patki VM; Kulkarni AD
    Indian J Biochem; 1970 Sep; 7(3):210-1. PubMed ID: 4252584
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors affecting release of medicaments from hard gelatin capsules.
    Juhl RP; Blaug SM
    J Pharm Sci; 1973 Jan; 62(1):170. PubMed ID: 4682927
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel starch-based PVA thermoplastic capsules for hydrophilic lipid-based formulations.
    Misic Z; Muffler K; Sydow G; Kuentz M
    J Pharm Sci; 2012 Dec; 101(12):4516-28. PubMed ID: 22949383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on dissolution tests for soft gelatin capsules by the rotating dialysis cell (RDC) method. VI. Preparation and evaluation of ibuprofen soft gelatin capsule.
    Takahashi M; Yuasa H; Kanaya Y; Uchiyama M
    Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1398-401. PubMed ID: 7553987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution testing of soft shell capsules-acetaminophen and nifedipine.
    Bottom CB; Clark M; Carstensen JT
    J Pharm Sci; 1997 Sep; 86(9):1057-61. PubMed ID: 9294822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A; El-Menshawe S; Afouna M
    Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
    Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.